Assessing Symptom Burden and Health-Related Quality of Life in patients living with arrhythmia and ASTA Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia
نویسندگان
چکیده
.................................................................................................................. 1 LIST OF PAPERS ........................................................................................................ 3 ABBREVIATIONS ....................................................................................................... 5 INTRODUCTION ......................................................................................................... 7 AIMS OF THE THESIS ............................................................................................... 9 BACKGROUND ......................................................................................................... 11 Arrhythmias ......................................................................................................... 11 Definition, prevalence and diagnosis .................................................................. 11 AV-Nodal reentry tachycardia and Wolff-Parkinson-White syndrome .......... 11 Atrial fibrillation .............................................................................................. 12 Other arrhythmias ............................................................................................... 12 Atrial flutter ..................................................................................................... 12 Other atrial macro-reentry arrhythmias ........................................................... 13 Focal Atrial Tachycardia ................................................................................. 13 Ventricular arrhythmias ................................................................................... 13 Treatment options for arrhythmia-patients ...................................................... 14 Symptoms and symptom burden ........................................................................ 15 Health, Quality of Life and Health-Related Quality of Life ............................ 16 Health and Quality of Life ............................................................................... 16 Health-Related Quality of Life ........................................................................ 17 Assessment of symptom burden and Health-Related Quality of Life in arrhythmia-patients with patient-reported outcomes ....................................... 18 Conceptualizing assessment of symptom burden and Health-Related Quality of Life .................................................................................................................... 20 Conceptualizing symptom burden and Health-Related Quality of Life assessment in the ASTA questionnaire ............................................................ 21 Conceptual model for the development of the disease-specific questionnaire ASTA ............................................................................................................... 22 METHODS .................................................................................................................. 23 Design and Setting................................................................................................ 23 Participants ........................................................................................................... 26 Study I .............................................................................................................. 26 Study II ............................................................................................................ 26 Study III ........................................................................................................... 27 Study IV ........................................................................................................... 28 Data collection ...................................................................................................... 30 Procedures ........................................................................................................ 30 Questionnaires used in the studies ..................................................................... 31 SF-36 ................................................................................................................ 31 EQ-5D .............................................................................................................. 32 SCL .................................................................................................................. 32 Development of the ASTA questionnaire .......................................................... 33 ASTA symptom burden ................................................................................... 33 ASTA Health-Related Quality of Life ............................................................. 34 Development and initial testing of the ASTA questionnaire ........................... 35 Statistical analysis of data ................................................................................... 39 Statistical tests in Studies I and II .................................................................... 39 Statistical tests in Studies III and IV ................................................................ 40 ETHICAL CONSIDERATIONS ............................................................................... 43 RESULTS .................................................................................................................... 45 Symptom burden .................................................................................................. 45 Health-Related Quality of Life ........................................................................... 46 The ASTA questionnaire ..................................................................................... 47 Data quality ...................................................................................................... 48 Validity ............................................................................................................ 48 Reliability (homogeneity) ................................................................................ 52 DISCUSSION .............................................................................................................. 53 Symptom burden .................................................................................................. 53 Health-Related Quality of Life ........................................................................... 54 The ASTA questionnaire ..................................................................................... 57 Data quality ...................................................................................................... 57 Validity ............................................................................................................ 58 Reliability (homogeneity) ................................................................................ 60 Methodological issues and limitations in Studies I-IV ..................................... 62 CONCLUSION ........................................................................................................... 65 CLINICAL IMPLICATIONS ................................................................................... 66 FUTURE ...................................................................................................................... 67 SVENSK SAMMANFATTNING .............................................................................. 68 ACKNOWLEDGEMENTS ....................................................................................... 70 APPENDIX 1 ............................................................................................................... 74 The ASTA questionnaire ..................................................................................... 74 ASTA background data ................................................................................... 74 ASTA symptom burden ................................................................................... 74 ASTA Health-Related Quality of Life ............................................................. 74 Recommendations for scoring of the ASTA questionnaire .............................. 75 General scoring information ............................................................................ 75 ASTA symptom burden scale .......................................................................... 75 ASTA symptoms near syncope and syncope................................................... 75 ASTA Health-Related Quality of Life ............................................................. 75 Transforming of scale scores ........................................................................... 76 REFERENCES ............................................................................................................ 79
منابع مشابه
Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden
BACKGROUND Arrhythmias can appear with a variety of symptoms, all from vague to pronounced and handicapping symptoms. Therefore, patient-reported outcomes (PROs) concerning symptom burden are important to assess and take into consideration in the care and treatment of patients with arrhythmias. The main purpose was to develop and validate a disease-specific questionnaire evaluating symptom burd...
متن کاملRadiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
AIMS The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation (RFA) vs. antiarrhythmic drug therapy (AAD) as first-line treatment for patients with PAF. In this substudy, we evaluated the effect of these treatment modalities on the Health-Related Quality ...
متن کاملNew Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation
INTRODUCTION Acceptance of illness plays a key role, allowing the patient to adapt to the disease and its treatment, and to maintain their health-related quality of life (HRQOL) despite chronic conditions. AIM The aim of the study was to assess the relationship between severity of arrhythmia symptoms, acceptance of illness and HRQOL in patients with atrial fibrillation. METHODS The study in...
متن کاملThe Effect of Opium Addiction on Cardiac Arrhythmia after Acute Myocardial Infarction
Background & Aims: This study was carried out to assess the effect of opium addiction on the incidence of different types of arrhythmias after acute myocardial infarction (AMI). Methods: The study population consisted of 200 patients with first AMI admitted within 6 hours of the onset of chest pain to the coronary care units (CCU) of two hospitals affiliated to Kerman University of Medical Scie...
متن کاملFrequency of Cardiac Arrhythmias in Patients with Aluminum Phosphide Poisoning
Background: Cardiac failure is the major lethal consequence of aluminum phosphide (AlP) poisoning. This study was designed to determine the frequency of cardiac arrhythmias in patients with AlP poisoning. Methods: In this prospective cross-sectional study, patients with definitive history of AlP poisoning treated at emergency department of Allied Hospital Faisalabad, Faisalabad, Pakistan, from ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2011